Intravenous Solutions Market Overview 2022-2027:
According to the latest report by IMARC Group, titled “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on Intravenous Solutions market trends. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027.
Intravenous (IV) solutions are fluids that consist of water, electrolytes, sugar, and medications. They can be administered directly into the bloodstream via a vein. At present, they are widely used to provide nutrients to patients suffering from cancer, diabetes, and other diseases.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Intravenous Solutions Market Trends:
Over the past few years, the prevalence of hectic work schedules and unhealthy lifestyles has increased across the globe. The consequent decline in physical activity and proper nutrition has led to a rise in the incidences of chronic diseases, which in turn has boosted the demand for intravenous solutions. Besides, there has been significant growth in the production of IV fluids, particularly in developed countries.
For instance, it was reported that due to the shortage of IV saline, the US Food and Drug Administration (FDA) and other market players have been making efforts to mitigate the crisis. In line with this, the US-based marketing and technology company, Merge, partnered with the innovative medical products and services provider, B. Braun Medical, to introduce the ‘Solutions for Life’ omnichannel campaign in May 2019. This initiative is aimed to ensure a consistent supply of IV solutions, approved by the US FDA, across the country.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/chewing-gum-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Braun Melsungen
- Baxter International Inc.
- Otsuka Pharmaceutical
Intravenous Solutions Market Segmentation:
Our report has categorized the market based on region, type and nutrients.
Market Breakup by Type:
- Partial Parenteral Nutrition
- Total Parenteral Nutrition
Market Breakup by Nutrients:
- Salts and Electrolytes
- Amino Acids
Market Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800